Isethionic acid sodium salt
CAS No. 1562-00-1
Isethionic acid sodium salt ( Sodium isethionate )
产品货号. M19983 CAS No. 1562-00-1
2-Hydroxyethanesulfonate (2-Hydroxyethanesulfonic acid or isethionic acid) is an organosulfur compound containing a short chain alkane sulfonate linked to a hydroxyl group.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥332 | 有现货 |
|
1G | ¥535 | 有现货 |
|
生物学信息
-
产品名称Isethionic acid sodium salt
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述2-Hydroxyethanesulfonate (2-Hydroxyethanesulfonic acid or isethionic acid) is an organosulfur compound containing a short chain alkane sulfonate linked to a hydroxyl group.
-
产品描述2-Hydroxyethanesulfonate (2-Hydroxyethanesulfonic acid or isethionic acid) is an organosulfur compound containing a short chain alkane sulfonate linked to a hydroxyl group. Mammals are able to endogenously synthesize 2-hydroxyethanesulfonate via taurine through a possible enzymatic deamination process. 2-Hydroxyethanesulfonate can be found in both human plasma and urine. Higher plasma levels of 2-hydroxyethanesulfonate have been shown to be protective against type 2 diabetes.
-
同义词Sodium isethionate
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1562-00-1
-
分子量148.11
-
分子式C2H5NaO4S
-
纯度>98% (HPLC)
-
溶解度DMSO:200 mM
-
SMILES[Na+].OCCS([O-])(=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sturman JA et al. Metabolism of [35S]taurine in man. J Nutr. 1975 Sep;105(9):1206-14.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Sylvestroside I
Sylvestroside I may have analgesic effect.
-
8-Prenylkaempferol
8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.